Memory loss may linger eight months after mild coronavirus infection, study finds
By
Alicia Lasek
Aug 17, 2021
The results suggest that COVID-19 may not really be a mild disease, no matter its course, investigators say. They also raise the question of whether current home-treatment strategies are optimal for long-term...
As COVID-19 cases rise, West Virginia to measure antibody levels of vaccinated nursing home residents
By
Caroline Szachnowski
Aug 02, 2021
Last winter, West Virginia worked to ensure those in nursing homes received the COVID-19 vaccines. However, with COVID-19 cases and hospitalizations increasing once again, state officials now are questioning...
GAO: Nursing homes unlikely to use point-of-care COVID tests in states that question accuracy
By
Alicia Lasek
Jan 29, 2021
A disconnect between federal and state or local policies has a direct effect on POC antigen test use in these settings, according to a comprehensive report released Thursday by the U.S. Government Accountability...
Nursing homes struggling with nuances of federal visitation policy
By
Kimberly Marselas
Mar 19, 2021
A week and a half after nursing home operators across the country learned they could open their doors to visitors, many are still grappling with the nuances of new visitation guidelines issued by the Centers...
‘Universal and persistent’: Surfaces near nursing home beds may harbor coronavirus for days
By
Alicia Lasek
Nov 16, 2021
Surfaces in 90% of COVID-19 patients’ rooms were contaminated with the SARS-CoV-2 virus, most commonly bed and TV remote controls, nurse call buttons, window sills and door knobs, investigators say.
CDC: Prepare for rebound in TB cases post-pandemic
By
Alicia Lasek
Mar 21, 2022
A 20% decline in tuberculosis cases in 2020 may be followed by an uptick once the COVID-19 pandemic wanes, according to CDC investigators. Clinicians should be prepared to detect cases and control spread,...
Regular physical activity cuts risk for severe COVID-19
By
Amy Novotney
Apr 19, 2021
Regular physical activity may substantially reduce the risk of COVID-19–related hospitalization, intensive care unit admission and death, according to an observational study of almost 50,000 people.
Effectiveness of mRNA COVID-19 vaccines lower at ≥120 days
Dec 09, 2021
Among U.S. veterans, VE was 86 percent for Moderna and 75 percent for PfizerBioNTech vaccines at ≥120 days after the second dose
Monoclonal antibodies excel in treating COVID-19 breakthrough cases, Mayo Clinic says
By
Alicia Lasek
Nov 19, 2021
Monoclonal antibody treatment lowers the odds of hospitalization by 77% in patients with COVID-19 breakthrough infections, investigators say. These SARS-CoV-2 reinfections have become more common in long-term...
An antibody cocktail that halts disease progression in sick COVD-19 patients has been shown to prevent the disease altogether in healthy people who live in close contact with an infected person, the drugmaker...